In a merger that combines two top companies in the rapidly growing field of genetic sequencing and testing, a team of Wilmer Cutler Pickering Hale and Dorr lawyers are advising Waltham, Massachusettsbased health care and laboratory equipment maker Thermo Fisher Scientific on its $13.6 billion acquisition of Life Technologies Corp. Once debt is included, the total deal value approaches $15.8 billion.
David Redlick, cochair of Wilmer’s life sciences group, is leading a Bostonbased team advising Thermo Fisher that also includes bankruptcy and restructuring practice chair John Sigel, M&A cochair Hal Leibowitz, corporate partner Erika Robinson, and commercial finance counsel Kathryn Bennett. None of the Wilmer lawyers working on the deal immediately responded to requests for comment. Like many Am Law 100 firms, Wilmer’s Boston office was closed Monday in observance of Patriots’ Day.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
